Pierre Boulanger

Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu

N. Habib, S. Ståhl, S. S. Hong, 2007, Cancer Gene Therapy.

Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A.

P. Nygren, E. Gunneriusson, S. S. Hong, 2002, Human gene therapy.

Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains

P. Nygren, S. S. Hong, P. Boulanger, 2005, Gene Therapy.

Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response

B. Quesnel, J. Beauvillain, P. Boulanger, 2010, Gene Therapy.

Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity.

S. S. Hong, P. Boulanger, Saw-See Hong, 1999, Human gene therapy.

Biochemical study of KB-cell receptor for adenovirus.

P. Boulanger, B. Hennache, Pierre Boulanger, 1977, The Biochemical journal.